Healthcare Realty Trust's reported revenue has contracted roughly 9.4% from $316.3M in 2024Q2 to $286.6M in 2026Q3, and total assets fell about 24% to $9.0B, suggesting portfolio dispositions are reshaping the business more than organic growth is.
Price trend, volume and key moving averages
Trailing total returns as of 11/8/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q4 2026Latest Oct 29, 2026 | -$0.05-736.9% vs $0.01 | $287M+4.1% vs $275M |
Q3 2026 Jul 30, 2026 | -$0.13-3276.6% vs -$0.00 | $282M+3.8% vs $272M |
Q2 2026 Apr 30, 2026 | $0.41+5.1% vs $0.39 | $279M-1.7% vs $284M |
Q1 2026 Feb 12, 2026 | $0.04-90.0% vs $0.40 | $286M+0.4% vs $285M |
Summit Therapeutics Inc. (Nasdaq: SMMT) today noted that its partner Akeso Inc. announced positive results from the Phase III HARMONi-GI1 study evaluating the n
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim an
Apple just got cut, BlackRock got a lift, and chipmakers are under pressure ahead of a week packed with big-tech earnings. Find out which stocks Wall Street is moving on Tuesday and why the calls matter right now.
Lilly to showcase advances across its oncology pipeline at the 2026 European Society for Medical Oncology (ESMO) CongressPR NewswireINDIANAPOLIS, Oct. 18, 2026F
Benchmark HR against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Healthcare Realty Trust Incorporated (HR)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $19.20 | $6.73B | -145.56 | -6.92% | -3.96% | -1.02% | 5.76% | |
| $20.26 | $13.97B | 35.99 | 4.52% | 12.66% | 4.13% | 6.02% | |
| $88.75 | $43.15B | 173.41 | 18.47% | 3.91% | 1.85% | 2.09% | |
| $245.01 | $176.55B | 126.51 | 35.82% | 10.67% | 3.15% | 1.13% | |
| $48.19 | $14.35B | 20.31 | 13.95% | 57.66% | 13.66% | 5.21% | |
| $28.70 | $379.92M | 7.09 | 16.34% | 34.26% | 8.88% | 13.62% |
Healthcare Realty Trust Incorporated (HR) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Healthcare Realty Trust Incorporated (HR) SEC filings — annual & quarterly reports (10-K, 10-Q)
Oct 29, 2026·SEC
Jul 31, 2026·SEC
Jul 30, 2026·SEC
Get notified when HR posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Healthcare Realty Trust Incorporated (HR) stock FAQ — growth, dividends, profitability & financials explained
Healthcare Realty Trust Incorporated (HR) reported $1.13B in revenue over the trailing twelve months. Revenue was $1.18B in fiscal year 2025. That is 3672% more than the $31.3M of fiscal year 1996.
Healthcare Realty Trust Incorporated (HR) revenue fell by 5.8% over the trailing twelve months, compared with the twelve months before.
No. Healthcare Realty Trust Incorporated (HR) reported a net loss of $44.9M over the trailing twelve months.
Yes. Healthcare Realty Trust Incorporated (HR) pays a dividend that yields 5.76% at the current price, a high yield.
Healthcare Realty Trust Incorporated (HR) had a return on equity (ROE) of -1.0% over the trailing twelve months. A negative ROE means the company lost money over the period.
Healthcare Realty Trust Incorporated (HR) generated Funds From Operations (FFO) of $502.7M in the trailing twelve months. FFO is the primary profitability metric for REITs.
Healthcare Realty Trust Incorporated (HR) offers a 5.76% dividend yield, which is attractive for income investors. REITs are required to distribute at least 90% of taxable income to shareholders.
